Integration of local and central laboratory functions in a worldwide multicentre study: Experience from the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study

Author:

,Nesbitt G Selby1,Smye Michael1,Sheridan Brian1,Lappin Terence RJ2,Trimble Elisabeth R3

Affiliation:

1. Department of Clinical Biochemistry, Royal Victoria Hospital, Belfast BT12 6BA, UK

2. Department of Haematology, Royal Victoria Hospital, Belfast BT12 6BA, UK, Haematology, Queen’s University Belfast, Belfast BT9 7AB, UK

3. Department of Clinical Biochemistry, Royal Victoria Hospital, Belfast BT12 6BA, UK, Clinical Biochemistry and Metabolic Medicine, Queen’s University Belfast, Belfast BT12 6BJ, UK,

Abstract

Background Measurement of glucose in multiple Field Laboratories requires rigorous standardization when patients and caregivers are masked, unless predefined thresholds are met. Local misclassification of participants at the thresholds can introduce recruitment bias and adversely affect the integrity of study findings. Purpose To describe the challenges and the approach to meeting them in measuring glucose, HbA1c, and C-peptide in the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. HAPO is an observational epidemiologic study of 25 000 pregnant women from 15 centres in 10 countries, designed to clarify unanswered questions on associations of maternal glycemia, less severe than overt diabetes mellitus, with risks of adverse pregnancy outcome. Methods Glucose tolerance (75 g two-hour OGTT) is assessed locally at 24-32 weeks’ gestation, with results masked if fasting and two-hour plasma glucose are ≤5.8 mmol/L and ≤11.1 mmol/L, respectively. For analysis of outcomes HAPO utilizes measurements of glucose, C-peptide, and HbA1c on frozen samples in a Central Laboratory; measurement of HbA1c on stored, frozen blood also creates special challenges. A common external quality assessment scheme was used to standardize glucose measurements between Field Centre and Central Laboratories before and during data collection. Results Agreement between Field Centres and the Central Laboratory in rates above the masking thresholds has been excellent (Kappa = 0.79, P < 0.001), with rates of 1.8 and 1.7% respectively. Percent technical error for Central Laboratory OGTT measurements of glucose, C-peptide, and HbA1c, were 2.0, 4.2, and 2.0, respectively. Limitations It is not possible to assess if comparable results could have been obtained with a less rigorous approach to standardization. Conclusions HAPO has been successful in ensuring comparability of glucose measurement between its Central Laboratory and Field Centre laboratories and in measuring its key metabolites with accuracy and precision. Recruitment bias based on glucose measurement has been avoided.

Publisher

SAGE Publications

Subject

Pharmacology,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3